CoChat

Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity

Open access
Yang, Shi-Bing, Lee, Hye Young, Young, David Matthew, Tien, An-Chi, Rowson-Baldwin, Ashley, Shu, Yu Yu, Jan, Yuh Nung, Jan, Lily Yeh · 2012 · Journal of Molecular Medicine
Cited by 103

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Rapamycin, a specific inhibitor for mTOR complex 1, is an FDA-approved immunosuppressant for organ transplant. Recent developments have raised the prospect of using rapamycin to treat cancer or diabetes and to delay aging. It is therefore important to assess how rapamycin treatment affects glucose homeostasis. Here, we show that the same rapamycin treatment reported to extend mouse life span significantly impaired glucose homeostasis of aged mice. Moreover, rapamycin treatment of lean C57B/L6 mice reduced glucose-stimulated insulin secretion in vivo and ex vivo as well as the insulin content and beta cell mass of pancreatic islets. Confounding the diminished capacity for insulin release, rapamycin decreased insulin sensitivity. The multitude of rapamycin effects thus all lead to glucose intolerance. As our findings reveal that chronic rapamycin treatment could be diabetogenic, monitoring glucose homeostasis is crucial when using rapamycin as a therapeutic as well as experimental reagent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00109-011-0834-3

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 103

Metadata

Authors
Yang, S.-B., Lee, H. Y., Young, D. M., Tien, A.-C., Rowson-Baldwin, A., Shu, Y. Y., Jan, Y. N., & Jan, L. Y.
Venue
Journal of Molecular Medicine
Published
2011-11-22
Volume
90
Issue
5
Pages
575-585
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W1968341708
Cited by
103
References
10
FWCI
10.85
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity. https://app.cochat.ai/papers/10.1007/s00109-011-0834-3
The paper
Yang, S.-B., Lee, H. Y., Young, D. M., Tien, A.-C., Rowson-Baldwin, A., Shu, Y. Y., Jan, Y. N., & Jan, L. Y. (2012). Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-011-0834-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.